Nearly 500,000 women are using menopause hormone therapy (MHT) in 2025, marking a steady increase in prescriptions since 2022, according to data from the Epi-phare pharmacovigilance network. The findings indicate a rising trend in the utilization of these treatments to manage menopausal symptoms.
How many women are currently using hormone therapy?
As of 2025, the number of women receiving menopause hormone treatment has reached nearly 500,000. According to the data released by Epi-phare, this figure represents a growth in the patient population relying on these medications compared to levels recorded three years prior.
What does the trend since 2022 indicate?
Prescription rates for MHT have climbed consistently since 2022. While the source does not specify the exact percentage of the increase, the Epi-phare report confirms that more women are accessing these treatments now than at the start of the three-year tracking period. This suggests a shift in how menopausal health is being managed or a change in patient and provider preferences regarding hormone replacement.
Who is monitoring these prescription trends?
The data comes from Epi-phare, a French pharmacovigilance system. This network monitors the use and safety of medications in real-world settings to provide public health authorities with accurate data on drug utilization and potential adverse effects.
